4//SEC Filing
Bloom Steven H. 4
Accession 0000950170-25-062970
CIK 0001785530other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:38 PM ET
Size
5.7 KB
Accession
0000950170-25-062970
Insider Transaction Report
Form 4
Bloom Steven H.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-01+201,720→ 201,720 totalExercise: $0.87Exp: 2035-04-30→ Common Stock (201,720 underlying)
Footnotes (1)
- [F1]The option was granted as an inducement material to Mr. Bloom's entering into employment with Werewolf Therapeutics, Inc. (the "Company") in accordance with Nasdaq Listing Rule 5635(c)(4). The option has a ten-year term and vests as to 25% on April 16, 2026, the first anniversary of the effective date of Mr. Bloom's employment, and the remaining 75% vests in 36 equal monthly installments thereafter, subject to continued service by Mr. Bloom to the Company or any of its subsidiaries through each applicable vesting date.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001722642
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:38 PM ET
- Size
- 5.7 KB